These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 2516584

  • 21. The effect of aromatase inhibitor 4-hydroxyandrostenedione on steroid receptors in hormone-dependent tissues of the rat.
    Zhou JL, Brodie A.
    J Steroid Biochem Mol Biol; 1995 Jan; 52(1):71-6. PubMed ID: 7857875
    [Abstract] [Full Text] [Related]

  • 22. 6-Methylenandrosta-1,4-diene-3,17-dione (FCE 24304): a new irreversible aromatase inhibitor.
    Giudici D, Ornati G, Briatico G, Buzzetti F, Lombardi P, di Salle E.
    J Steroid Biochem; 1988 Jan; 30(1-6):391-4. PubMed ID: 3386266
    [Abstract] [Full Text] [Related]

  • 23. Inhibition of growth and appearance of estrogen-dependent rat mammary tumors by 10-propargylestr-4-ene-3,17-dione, an aromatase inhibitor.
    Zimniski SJ, Brandt ME, Covey DF, Puett D.
    Breast Cancer Res Treat; 1993 Jan; 26(1):15-21. PubMed ID: 8400320
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Aromatase inhibitors and the treatment of breast cancer.
    Brodie AM, Wing LY, Goss P, Dowsett M, Coombes RC.
    J Steroid Biochem; 1986 Jan; 24(1):91-7. PubMed ID: 3702431
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Effect of an aromatase inhibitor, 1,4,6-androstatriene-3,17-dione, on 7,12-dimethylbenz[a]anthracene-induced mammary tumors in the rat and its mechanism of action in vivo.
    Brodie AM, Brodie HJ, Garrett WM, Hendrickson JR, Marsh DA, Tsai-Morris CH.
    Biochem Pharmacol; 1982 Jun 01; 31(11):2017-23. PubMed ID: 6810900
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Antitumor effects of SEF19, a new nonsteroidal aromatase inhibitor, on 7,12-dimethylbenz[a]anthracene-induced mammary tumors in rats.
    Iino Y, Karakida T, Sugamata N, Andoh T, Takei H, Takahashi M, Yaguchi S, Matsuno T, Takehara M, Sakato M, Kawashima S, Morishita Y.
    Anticancer Res; 1998 Jun 01; 18(1A):171-6. PubMed ID: 9568073
    [Abstract] [Full Text] [Related]

  • 38. The effect of an aromatase inhibitor, 4-hydroxy-4-androstene-3,17-dione, on estrogen-dependent processes in reproduction and breast cancer.
    Brodie AM, Schwarzel WC, Shaikh AA, Brodie HJ.
    Endocrinology; 1977 Jun 01; 100(6):1684-95. PubMed ID: 404132
    [Abstract] [Full Text] [Related]

  • 39. Biological characterization of A-ring steroids.
    Johnston JO, Wright CL, Burkhart JP, Peet NP.
    J Steroid Biochem Mol Biol; 1993 Mar 01; 44(4-6):623-31. PubMed ID: 8476773
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.